TY - JOUR
T1 - Defining treatment response in trichotillomania
T2 - A signal detection analysis
AU - Houghton, David C.
AU - Capriotti, Matthew R.
AU - De Nadai, Alessandro S.
AU - Compton, Scott N.
AU - Twohig, Michael P.
AU - Neal-Barnett, Angela M.
AU - Saunders, Stephen M.
AU - Franklin, Martin E.
AU - Woods, Douglas W.
N1 - Publisher Copyright:
© 2015 Elsevier Ltd.
PY - 2015/12/1
Y1 - 2015/12/1
N2 - The Massachusetts General Hospital Hairpulling Scale (MGH-HPS) and the NIMH Trichotillomania Severity Scale (NIMH-TSS) are two widely used measures of trichotillomania severity. Despite their popular use, currently no empirically-supported guidelines exist to determine the degrees of change on these scales that best indicate treatment response. Determination of such criteria could aid in clinical decision-making by defining clinically significant treatment response/recovery and producing accurate power analyses for use in clinical trials research. Adults with trichotillomania (. N=69) participated in a randomized controlled trial of psychotherapy and were assessed before and after treatment. Response status was measured via the Clinical Global Impressions-Improvement Scale, and remission status was measured via the Clinical Global Impressions-Severity Scale. For treatment response, a 45% reduction or 7-point raw score change on the MGH-HPS was the best indicator of clinically significant treatment response, and on the NIMH-TSS, a 30-40% reduction or 6-point raw score difference was most effective cutoff. For disorder remission, a 55-60% reduction or 7-point raw score change on the MGH-HPS was the best predictor, and on the NIMH-TSS, a 65% reduction or 6-point raw score change was the best indicator of disorder remission. Implications of these findings are discussed.
AB - The Massachusetts General Hospital Hairpulling Scale (MGH-HPS) and the NIMH Trichotillomania Severity Scale (NIMH-TSS) are two widely used measures of trichotillomania severity. Despite their popular use, currently no empirically-supported guidelines exist to determine the degrees of change on these scales that best indicate treatment response. Determination of such criteria could aid in clinical decision-making by defining clinically significant treatment response/recovery and producing accurate power analyses for use in clinical trials research. Adults with trichotillomania (. N=69) participated in a randomized controlled trial of psychotherapy and were assessed before and after treatment. Response status was measured via the Clinical Global Impressions-Improvement Scale, and remission status was measured via the Clinical Global Impressions-Severity Scale. For treatment response, a 45% reduction or 7-point raw score change on the MGH-HPS was the best indicator of clinically significant treatment response, and on the NIMH-TSS, a 30-40% reduction or 6-point raw score difference was most effective cutoff. For disorder remission, a 55-60% reduction or 7-point raw score change on the MGH-HPS was the best predictor, and on the NIMH-TSS, a 65% reduction or 6-point raw score change was the best indicator of disorder remission. Implications of these findings are discussed.
KW - Hair pulling
KW - Obsessive-compulsive disorder
KW - Psychotherapy
KW - Signal detection
KW - Trichotillomania
UR - http://www.scopus.com/inward/record.url?scp=84942523224&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942523224&partnerID=8YFLogxK
U2 - 10.1016/j.janxdis.2015.09.008
DO - 10.1016/j.janxdis.2015.09.008
M3 - Article
C2 - 26422605
AN - SCOPUS:84942523224
SN - 0887-6185
VL - 36
SP - 44
EP - 51
JO - Journal of Anxiety Disorders
JF - Journal of Anxiety Disorders
ER -